Effects of three months' diet after diagnosis of Type 2 diabetes on plasma lipids and lipoproteins (UKPDS 45). UK Prospective Diabetes Study Group.

PubWeight™: 2.20‹?› | Rank: Top 2%

🔗 View Article (PMID 10972581)

Published in Diabet Med on July 01, 2000

Authors

S E Manley1, I M Stratton, C A Cull, V Frighi, E A Eeley, D R Matthews, R R Holman, R C Turner, H A Neil, United Kingdom Prospective Diabets Study Group

Author Affiliations

1: Diabetes Trials Unit, Oxford Centre for Diabetes, Endocrinology & Metabolism, University of Oxford, UK. susan.manley@dtu.ox.ac.uk

Articles by these authors

Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia (1985) 109.13

Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study. BMJ (2000) 35.06

Publication bias in clinical research. Lancet (1991) 22.85

Effect of rosiglitazone on the frequency of diabetes in patients with impaired glucose tolerance or impaired fasting glucose: a randomised controlled trial. Lancet (2006) 15.32

Management of hyperglycaemia in type 2 diabetes: a patient-centered approach. Position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetologia (2012) 10.74

Association of systolic blood pressure with macrovascular and microvascular complications of type 2 diabetes (UKPDS 36): prospective observational study. BMJ (2000) 10.66

Glycemic control with diet, sulfonylurea, metformin, or insulin in patients with type 2 diabetes mellitus: progressive requirement for multiple therapies (UKPDS 49). UK Prospective Diabetes Study (UKPDS) Group. JAMA (1999) 10.52

The UKPDS risk engine: a model for the risk of coronary heart disease in Type II diabetes (UKPDS 56). Clin Sci (Lond) (2001) 8.45

Correct homeostasis model assessment (HOMA) evaluation uses the computer program. Diabetes Care (1998) 8.29

Medical management of hyperglycaemia in type 2 diabetes mellitus: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement from the American Diabetes Association and the European Association for the Study of Diabetes. Diabetologia (2008) 8.02

Metformin. N Engl J Med (1996) 7.66

A sensitive, precise radioimmunoassay of serum insulin relying on charcoal separation of bound and free hormone moieties. Acta Endocrinol (Copenh) (1972) 7.64

Risk factors for coronary artery disease in non-insulin dependent diabetes mellitus: United Kingdom Prospective Diabetes Study (UKPDS: 23) BMJ (1998) 7.48

Intensive glucose control and macrovascular outcomes in type 2 diabetes. Diabetologia (2009) 6.55

UKPDS 50: risk factors for incidence and progression of retinopathy in Type II diabetes over 6 years from diagnosis. Diabetologia (2001) 4.78

Purification and characterization of a peptide from amyloid-rich pancreases of type 2 diabetic patients. Proc Natl Acad Sci U S A (1987) 4.19

Management of hyperglycaemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy. A consensus statement from the American Diabetes Association and the European Association for the Study of Diabetes. Diabetologia (2006) 3.80

Psychosocial problems and barriers to improved diabetes management: results of the Cross-National Diabetes Attitudes, Wishes and Needs (DAWN) Study. Diabet Med (2005) 3.80

Lack of confidence among trainee doctors in the management of diabetes: the Trainees Own Perception of Delivery of Care (TOPDOC) Diabetes Study. QJM (2011) 3.46

The assessment of insulin resistance in man. Diabet Med (2002) 3.35

Islet amyloid, increased A-cells, reduced B-cells and exocrine fibrosis: quantitative changes in the pancreas in type 2 diabetes. Diabetes Res (1988) 3.10

Severe hypoglycemia and hyperinsulinemia in falciparum malaria. N Engl J Med (1983) 3.07

Systematic review of dietary intervention trials to lower blood total cholesterol in free-living subjects. BMJ (1998) 3.07

A model to estimate the lifetime health outcomes of patients with type 2 diabetes: the United Kingdom Prospective Diabetes Study (UKPDS) Outcomes Model (UKPDS no. 68). Diabetologia (2004) 3.01

Impact of pharmaceutical company representatives on internal medicine residency programs. A survey of residency program directors. Arch Intern Med (1992) 2.95

United Kingdom Prospective Diabetes Study, 30: diabetic retinopathy at diagnosis of non-insulin-dependent diabetes mellitus and associated risk factors. Arch Ophthalmol (1998) 2.93

Risk factors for stroke in type 2 diabetes mellitus: United Kingdom Prospective Diabetes Study (UKPDS) 29. Arch Intern Med (1999) 2.75

Linkage of type 2 diabetes to the glucokinase gene. Lancet (1992) 2.64

Cancer outcomes and all-cause mortality in adults allocated to metformin: systematic review and collaborative meta-analysis of randomised clinical trials. Diabetologia (2012) 2.53

Impaired pulsatile secretion of insulin in relatives of patients with non-insulin-dependent diabetes. N Engl J Med (1988) 2.43

Decreases in albumin/creatinine and N-acetylglucosaminidase/creatinine ratios in urine samples stored at -20 degrees C. Clin Chem (1992) 2.41

Extent of underdiagnosis of familial hypercholesterolaemia in routine practice: prospective registry study. BMJ (2000) 2.40

Validation of an algorithm combining haemoglobin A(1c) and fasting plasma glucose for diagnosis of diabetes mellitus in UK and Australian populations. Diabet Med (2009) 2.38

Additive effects of glycaemia and blood pressure exposure on risk of complications in type 2 diabetes: a prospective observational study (UKPDS 75). Diabetologia (2006) 2.37

Nesidioblastosis of the pancreas: definition of the syndrome and the management of the severe neonatal hyperinsulinaemic hypoglycaemia. Arch Dis Child (1981) 2.36

Small doses of intramuscular insulin in the treatment of diabetic "coma". Lancet (1973) 2.36

Recent advances in the monitoring and management of diabetic ketoacidosis. QJM (2004) 2.33

Prevalence and projections of diabetes and pre-diabetes in adults in Sri Lanka--Sri Lanka Diabetes, Cardiovascular Study (SLDCS). Diabet Med (2008) 2.26

Cyclic oscillations of basal plasma glucose and insulin concentrations in human beings. N Engl J Med (1979) 2.25

Weight loss with liraglutide, a once-daily human glucagon-like peptide-1 analogue for type 2 diabetes treatment as monotherapy or added to metformin, is primarily as a result of a reduction in fat tissue. Diabetes Obes Metab (2009) 2.23

Home blood sampling for plasma glucose assay in control of diabetes. Br Med J (1978) 2.22

UKPDS 26: Sulphonylurea failure in non-insulin-dependent diabetic patients over six years. UK Prospective Diabetes Study (UKPDS) Group. Diabet Med (1998) 2.20

Optimal insulin regimens in type 2 diabetes mellitus: systematic review and meta-analyses. Diabetologia (2009) 2.16

Islet amyloid formed from diabetes-associated peptide may be pathogenic in type-2 diabetes. Lancet (1987) 2.15

Insulin deficiency and insulin resistance interaction in diabetes: estimation of their relative contribution by feedback analysis from basal plasma insulin and glucose concentrations. Metabolism (1979) 2.07

Parent-offspring trios: a resource to facilitate the identification of type 2 diabetes genes. Diabetes (1999) 1.97

Survival in sinoatrial disorder (sick-sinus syndrome). Br Med J (1980) 1.94

Hypoglycaemia in African children with severe malaria. Lancet (1987) 1.88

Outcome of transphenoidal surgery for acromegaly and its relationship to surgical experience. Clin Endocrinol (Oxf) (1999) 1.85

A gene variant near ATM is significantly associated with metformin treatment response in type 2 diabetes: a replication and meta-analysis of five cohorts. Diabetologia (2012) 1.83

Can residents be trained to counsel patients about quitting smoking? Results from a randomized trial. J Gen Intern Med (1991) 1.81

Screening for hypercholesterolaemia versus case finding for familial hypercholesterolaemia: a systematic review and cost-effectiveness analysis. Health Technol Assess (2000) 1.80

Fate of research studies. J R Soc Med (1992) 1.79

Serum cortisol and 17-hydroxyprogesterone interrelation in classic 21-hydroxylase deficiency: is current replacement therapy satisfactory? J Clin Endocrinol Metab (2001) 1.78

A practical guide to basal and prandial insulin therapy. Diabet Med (1985) 1.76

Randomised trial of lipid lowering dietary advice in general practice: the effects on serum lipids, lipoproteins, and antioxidants. BMJ (1995) 1.75

Diabetes: The quest for basal normoglycaemia. Lancet (1977) 1.75

Approach to maintaining comparability of biochemical data during long-term clinical trials. Clin Chem (1997) 1.70